Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $955000.0.

  • InfuSystem Holdings' Cash & Equivalents rose 15131.58% to $955000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $955000.0, marking a year-over-year increase of 15131.58%. This contributed to the annual value of $527000.0 for FY2024, which is 12813.85% up from last year.
  • As of Q3 2025, InfuSystem Holdings' Cash & Equivalents stood at $955000.0, which was up 15131.58% from $720000.0 recorded in Q2 2025.
  • InfuSystem Holdings' Cash & Equivalents' 5-year high stood at $2.8 million during Q1 2021, with a 5-year trough of $134000.0 in Q2 2023.
  • Over the past 5 years, InfuSystem Holdings' median Cash & Equivalents value was $311000.0 (recorded in 2022), while the average stood at $545157.9.
  • Examining YoY changes over the last 5 years, InfuSystem Holdings' Cash & Equivalents showed a top increase of 80524.59% in 2021 and a maximum decrease of 9807.21% in 2021.
  • InfuSystem Holdings' Cash & Equivalents (Quarter) stood at $186000.0 in 2021, then fell by 11.29% to $165000.0 in 2022, then soared by 40.0% to $231000.0 in 2023, then skyrocketed by 128.14% to $527000.0 in 2024, then soared by 81.21% to $955000.0 in 2025.
  • Its Cash & Equivalents stands at $955000.0 for Q3 2025, versus $720000.0 for Q2 2025 and $1.5 million for Q1 2025.